Search results for "Dox"
showing 10 items of 1345 documents
The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
1998
Many anticancer drugs are able to induce apoptosis in tumor cells but the mechanisms underlying this phenomenon are poorly understood. Some authors reported that the p53 tumor suppressor gene may be responsible for drug-induced apoptosis; however, chemotherapy-induced apoptosis can also be observed in p53 negative cells. Recently, doxorubicin (DXR) was reported to induce CD95L expression to mediate apoptosis through the CD95/CD95L system. Thus, an impairment of such a system may be involved in drug resistance. We evaluated the in vitro antitumor activity of several cytotoxic drugs on two human p53-negative T-cell lymphoma cell lines, the HUT78-B1 CD95L-resistant cell line and the HUT78 pare…
Temperature Adaptation Markedly Determines Evolution within the Genus Saccharomyces
2011
12 pages, 7 figures, 3 tables
Catalytic oxidation and reduction of polycyclic aromatic hydrocarbons (PAHs) present as mixtures in hydrothermal media
2012
Author's version of an article in the journal: Polycyclic Aromatic Compounds. Also available from the publisher at: http://dx.doi.org/10.1080/10406638.2012.663451 The reactivity of fluorene, anthracene, and fluoranthene under oxidation and reduction conditions were investigated in this study. This project looks at catalytic and green approaches of converting PAHs to less toxic and/or less stable derivatives that are amenable to further degradation. Hydrothermal reactions have been performed at 300°C with pure H2O and Nafion-SiO2 catalyst for oxidation, and pure H2O, HCOOH, Pd-C, and Nafion-SiO2 catalysts for reductive hydrogenation. Time series has been performed for both the oxidation and …
Topological effects of a rigid chiral spacer on the electronic interactions in donor-acceptor ensembles
2005
Two triads (donor-spacer-acceptor), etTTF-BN-C 6 0 (6) and ZnP-BN-C 6 0 (7), in which electron donors (i.e., exTTF or ZnP) are covalently linked to C 6 0 through a chiral binaphthyl bridge (BN), have been prepared in a multistep synthetic procedure starting from a highly soluble enantiomerically pure binaphthyl building block (1). Unlike other oligomeric bridges, with hinaphthyl bridges, the conjugation between the donor and the acceptor units is broken and geometric conformational changes are facilitated. Consequently, distances and electronic interactions between the donor and C 6 0 are drastically changed. Both donor-spacer-acceptor (D-s-A) systems (i.e., 6 and 7) exhibit redox processes…
Synthesis of Silver Gallium Selenide (AgGaSe2) Nanotubes and Nanowires by Template-Based Electrodeposition
2020
In this work, a systematic investigation of the different parameters that control the electrodeposition processes was carried out at the aim to synthetizing AgGaSe₂ nanostructures. We found that pH is a key parameter to control both the morphology and composition of the nanostructures. Low pH favours mainly the formation of Ag2Se nanotubes with a scarce mechanical stability, while multi-phase nanowires well anchored to the substrate were obtained at higher pH. We also found that it was necessary to increase dramatically the concentration of the gallium precursor into the deposition bath in order to obtain AgGaSe₂ owing to lower redox potential of the Ga3+/Ga couple than Ag2+/Ag and Se4+/Se.…
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.
2015
Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.
MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
2016
Purpose: The purpose of the study is to compare the MR-imaging features of hepatocellular carcinoma (HCC) capsule appearance on gadoxetic acid and gadobenate dimeglumine-enhanced MR imaging, using imaging-based presumptive diagnosis of HCC as the reference standard. Methods: Gadoxetic acid and gadobenate dimeglumine-enhanced MR imaging of 51 patients with 71 HCCs were retrospectively reviewed. Three readers graded in consensus, using a five-point scale, the presence (score 4–5) of capsule appearance on images obtained during T1-weighted GRE portal venous phase (PVP), 3-min phase, and hepatobiliary phase (HBP). The Fisher's exact test and the t student unpaired test were performed. Results: …
Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?
2020
Purpose: To compare the level of parenchymal and portal venous enhancement in the portal venous phase (PVP) in cirrhotic patients undergoing gadoxetate disodium- and gadobenate dimeglumine-enhanced MRI. Methods: In this retrospective study, 84 cirrhotic patients (mean age ± SD: 66 ± 13 years) who underwent contrast-enhanced MRI with both gadoxetate disodium and gadobenate dimeglumine between 2012 and 2018 were included. Two readers measured signal intensities of hepatic parenchyma, portal vein and psoas muscle on precontrast and PVP. Relative enhancement (RE), image contrast, and portal vein-to-liver contrast difference were calculated. Intraindividual differences were compared with the Wil…
Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging
2021
Abstract Objectives The 9th International Forum for Liver Magnetic Resonance Imaging (MRI) was held in Singapore in September 2019, bringing together radiologists and allied specialists to discuss the latest developments in and formulate consensus statements for liver MRI, including the applications of gadoxetic acid–enhanced imaging. Methods As at previous Liver Forums, the meeting was held over 2 days. Presentations by the faculty on days 1 and 2 and breakout group discussions on day 1 were followed by delegate voting on consensus statements presented on day 2. Presentations and discussions centered on two main meeting themes relating to the use of gadoxetic acid–enhanced MRI in primary l…
Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation.
2019
Purpose: To investigate the clinical implications and natural history of observations showing a “nodule-in-nodule” architecture on hepatobiliary phase (HBP) in a cirrhotic population. Method: This is an IRB-approved retrospective study conducted in a single institution. We identified 20 patients (11 men and 9 women, mean age 71 years, range 51–83 years) who had a hyperintense nodule on HBP arising within a larger HBP-hypointense nodule without arterial phase hyperenhancement (APHE) at gadoxetate disodium-enhanced MRI. Size and signal intensity of the nodules were evaluated in all sequences, along with the evolution of the nodules at serial MRI studies. Results: Twenty-four…